46.42 F
Springfield
March 29, 2024
Image default
Business Culture

Pfizer says its COVID-19 vaccine is over 90 percent effective

Pfizer has been working with BioNTech on a vaccine for COVID-19, and their early analysis suggests their vaccine candidate is over 90% effective. That would be a much higher than expected rate of efficacy from one of the earliest vaccine candidates for the virus. The U.S. Food and Drug Administration is looking for at least 50% efficacy from a COVID-19 vaccine.Q3 2020 hedge fund letters, conferences and morePfizer vaccine may be very effectiveThe interim analysis focused on the first 94 confirmed cases of COVID-19 among the over 43,000 volunteers who received either two doses of the vaccine or…

Read More

Related posts

US population growth slows to lowest rate in over a century

The_Proponent

Bitcoin, ether hit all-time highs as momentum accelerates

The_Proponent

Overwatch star Ryujehong banned on Twitch, fans suspect DMCA

The_Proponent

Chris Evans Sends Captain America Shield To Boy Who Saved His Sister From Dog Attack

The_Proponent

Byte offers a credible alternative to TikTok

The_Proponent

Delta variant, shortages severely restrict U.S. economic growth in third quarter

The_Proponent

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.